Group One Trading’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-72,300
Closed -$6.72M 9117
2021
Q4
$6.72M Buy
72,300
+47,100
+187% +$3.1M 0.01% 1431
2021
Q3
$1.5M Sell
25,200
-19,900
-44% -$1.18M ﹤0.01% 2961
2021
Q2
$3.08M Buy
45,100
+27,700
+159% +$1.81M ﹤0.01% 2199
2021
Q1
$1.21M Buy
17,400
+11,100
+176% +$854K ﹤0.01% 3009
2020
Q4
$484K Sell
6,300
-63,300
-91% -$4.74M ﹤0.01% 3291
2020
Q3
$5.21M Sell
69,600
-1,400
-2% -$93.3K 0.02% 893
2020
Q2
$4.47M Buy
71,000
+66,700
+1,551% +$3.67M 0.02% 879
2020
Q1
$181K Sell
4,300
-6,200
-59% -$284K ﹤0.01% 2840
2019
Q4
$477K Sell
10,500
-2,600
-20% -$123K ﹤0.01% 2472
2019
Q3
$600K Sell
13,100
-8,500
-39% -$478K ﹤0.01% 2176
2019
Q2
$1.27M Buy
21,600
+10,600
+96% +$548K 0.01% 1438
2019
Q1
$493K Sell
11,000
-31,900
-74% -$1.46M 0.01% 1952
2018
Q4
$1.67M Sell
42,900
-44,100
-51% -$1.73M 0.01% 1144
2018
Q3
$4M Sell
87,000
-12,500
-13% -$507K 0.03% 701
2018
Q2
$4.34M Buy
99,500
+16,600
+20% +$713K 0.04% 619
2018
Q1
$3.27M Sell
82,900
-38,700
-32% -$1.51M 0.03% 688
2017
Q4
$4.13M Buy
121,600
+54,600
+81% +$1.56M 0.03% 743
2017
Q3
$1.71M Sell
67,000
-23,700
-26% -$544K 0.02% 1165
2017
Q2
$1.53M Buy
90,700
+84,920
+1,469% +$1.16M 0.02% 1135
2017
Q1
$84K Sell
5,780
-14,200
-71% -$210K ﹤0.01% 3090
2016
Q4
$284K Buy
+19,980
New +$309K ﹤0.01% 2183
2013
Q3
Sell
-90,220
Closed -$6.95M 5723
2013
Q2
$6.95M Buy
+90,220
New +$7.36M 0.17% 107

Group One Trading's ARNA Position: Q1 2022 in Review

Group One Trading sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 42,327 shares — an estimated $3.93M sold.

Group One Trading first reported a position in ARNA in Q3 2013 and held it in 24 quarters. The position peaked at $6.47M in Q3 2014. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

  • Group One Trading reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
  • Group One Trading sold 42,327 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $3.93M.
  • Group One Trading first reported a position in Arena Pharmaceuticals Inc in Q3 2013 and held it in 24 quarters.
  • Group One Trading's Arena Pharmaceuticals Inc position peaked at $6.47M in Q3 2014.
  • 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Group One Trading's 13F filing for Q1 2022, filed 12 May 2022.